|Publication number||US20040241768 A1|
|Application number||US 10/811,129|
|Publication date||Dec 2, 2004|
|Filing date||Mar 29, 2004|
|Priority date||May 8, 2000|
|Also published as||CA2409512A1, EP1301626A1, EP1301626A4, US6743640, US20020051985, WO2001085997A1|
|Publication number||10811129, 811129, US 2004/0241768 A1, US 2004/241768 A1, US 20040241768 A1, US 20040241768A1, US 2004241768 A1, US 2004241768A1, US-A1-20040241768, US-A1-2004241768, US2004/0241768A1, US2004/241768A1, US20040241768 A1, US20040241768A1, US2004241768 A1, US2004241768A1|
|Inventors||David Whitten, Duncan McBranch, Robert Jones, Troy Bergstedt|
|Original Assignee||Whitten David G., Mcbranch Duncan W., Robert Jones, Bergstedt Troy S.|
|Export Citation||BiBTeX, EndNote, RefMan|
|Patent Citations (99), Referenced by (30), Classifications (18)|
|External Links: USPTO, USPTO Assignment, Espacenet|
 This application claims priority from U.S. Provisional Application Ser. No. 60/202,647 filed May 8, 2000 and U.S. Provisional Application Ser. No. 60/226,902 filed Aug. 23, 2000. The entirety of those provisional applications are incorporated herein by reference.
 Field of the Invention
 The present invention relates to a fluorescent biosensor that functions by a novel Quencher-Tether-Ligand (QTL) mechanism. In particular, the polymer-QTL system provides for effective sensing of biological agents by observing fluorescence changes.
 The enzyme linked immunosorbant assay, ELISA, is the most widely used and accepted technique for identifying the presence and biological activity of a wide range of proteins, antibodies, cells, viruses, etc. It is a multi-step “sandwich assay” in which the analyte biomolecule is first bound to an antibody tethered to a surface. A second antibody then binds to the biomolecule. In some cases, the second antibody is tethered to a catalytic enzyme which subsequently “develops” an amplifying reaction. In other cases, this second antibody is biotinylated to bind a third protein (e.g., avidin or streptavidin). This protein is tethered either to an enzyme, which creates a chemical cascade for an amplified calorimetric change, or to a fluorophore, for fluorescent tagging.
 Despite its wide use, there are many disadvantages to ELISA. For example, because the multi-step procedure requires both precise control over reagents and development time, it is time-consuming and prone to “false positives”. Further, careful washing is required to remove nonspecific adsorbed reagents. On the other hand, the polymer-QTL (Quencher-Tether-Ligand) approach of the present invention is a single-step, instantaneous, homogeneous assay where the amplification step is intrinsic to the fluorescent conjugated polymer. Furthermore, there are no reagents. Thus, the process is uniquely robust, simple, and accurate relative to ELISA or other sensor techniques.
 Other technology advantages inherent in the polymer-QTL approach are similar to those used in fluorescence resonance energy transfer (FRET). FRET techniques have been applied to both polymerase chain reaction-based (PCT) gene sequencing and immunoassays. In particular, FRET uses homogeneous binding of an analyte biomolecule to activate the fluorescence of a dye that is quenched in the off-state. However, there are important limitations and differentiations to FRET relative to the polymer-QTL approach. In an example of FRET technology, a fluorescent dye is linked to an antibody (F—Ab), and this diad is bound to an antigen linked to a quencher (Ag—Q). The bound complex (F—Ab:Ag—Q) is quenched (i.e., non-fluorescent) by energy transfer. In the presence of identical analyte antigens which are untethered to Q (Ag), the Ag—Q diads are displaced quantitatively as determined by the equilibrium binding probability determined by the relative concentrations, [Ag—Q]/[Ag]. This limits the FRET technique to a quantitative assay where the antigen is already well-characterized, and the chemistry to link the antigen to Q must be worked out for each new case.
 On the other hand, the QTL assay works by selective binding to the quencher-tether-ligand. The competition between the binding of QTL to the polymer vs. the analyte may be widely controlled by varying the polymer and QTL structure and charge density. Even more importantly, the QTL assay uses a fluorescent polymer rather than a small molecular fluorophore. This fundamental difference between FRET techniques and QTL assays allows the polymer-QTL technology to have significant amplification in quenching and detection sensitivity. In addition, the polymer-QTL approach is immediately applicable to powerful combinatorial techniques for generating new molecular recognition species for unknown and uncharacterized biomolecules. Due to the sensitivity of fluorescence quenching in the QTL technology relative to FRET, QTL eliminates the need for pre-concentration of the sample, thereby allowing the use of microliter quantities of reagents in capillary tubes. The polymer-QTL approach also avoids the elaborate preprocessing required by polymerase chain reaction (PCR), offering significant incentives to the further development of the polymer-QTL approach for detection of nucleic acids.
 The ability to rapidly and accurately detect and quantify biologically relevant molecules with high sensitivity is a central issue for medical technology, national security, public safety, and civilian and military medical diagnostics. Many of the currently used approaches, including enzyme linked immunosorbant assays (ELISAs) and PCR are highly sensitive. However, they can be cumbersome and time-consuming, as discussed above. In order to address the problems in the art, the present inventors have developed a prototype for a new fluorescent biosensor which functions by a novel Quencher-Tether-Ligand (QTL) mechanism that provides a simple, rapid and highly-sensitive detection of biological molecules with structural specificity. The present invention may be adapted to a number of different formats ranging from a single or multiple species to medical diagnostics and fluorescent tags.
 It is an object of the present invention to provide a novel chemical moiety formed of a quencher (Q), a tethering element (T), and a ligand (L).
 It is another object of the present invention to provide a method of detecting target biological agents in a sample using the novel QTL molecule of the present invention and a fluorescent polymer.
 It is a further object of the present invention to detect target biological agents in a sample by observing fluorescent changes.
 It is a feature of the present invention that the change in fluorescence is indicative of the presence of the target biological agent.
 It is another feature of the present invention that the fluorescent polymer can be tethered to the novel QTL molecule.
 It is a further feature of the present invention that the fluorescent polymer used in detection can be anchored to a support.
 It is an object of the present invention to rapidly and accurately detect and quantify target biological molecules in a sample.
 It is a further feature of the invention that the fluorescent polymer comprises dye chromophores pendant as side chains of a polymeric backbone.
 It is an advantage of the present invention that target biological molecules can be detected at near single molecule levels.
 It is a further feature of the invention that detection of target molecules may be enhanced by application of electric fields.
 It is a further advantage of the present invention that it is simple and requires no elaborate preprocessing.
 These and other objects are met by a composition of matter comprising: a) a fluorescent polymer, and b) a chemical moiety QTL comprising a recognition element, which binds to a target biological agent, and a property-altering element which alters fluorescence emitted by the fluorescent polymer when complexed together to a distinguishable degree, bound together by a tethering element, the chemical moiety being adapted for complexation with the fluorescent polymer. In the presence of binding of the recognition element to said target biological agent, the fluorescence emitted by the polymer is altered from that emitted when binding between said recognition element and said target biological agent does not occur.
FIG. 1 is a Stern-Volmer plot of fluorescence intensity of the polymer MPS—PPV in the presence of methyl viologen (MV2+).
FIG. 2 is a general illustration of the mechanism of the present invention.
FIG. 3a is a graphical illustration of the relative fluorescence intensity for a sensor based on Stern-Volmer type quenching and recovery.
FIG. 3b is a graphical illustration of the sensitivity and dynamic range for a sensor based on Stern-Volmer type quenching and recovery.
FIG. 4 is a general illustration of the QTL approach.
FIG. 5 is a general illustration of an alternative QTL approach.
FIG. 6a is an illustration of a cyanine dye pendant (CDP) polymer.
FIG. 6b is a graphical illustration of a comparison of J-aggregated CDP and a conjugated polymer absorption and fluorescence spectra.
FIG. 7 is a graphical illustration of the variation of the quenching constant, Ksv, for J-aggregate CDP as a function of number of polymer repeat units (PRU).
FIG. 8a is a graphical illustration of quenchers per polymer at 50% quenching as a function of the number of polymer repeat units (PRU).
FIG. 8b is a logarithmic graph of the quenchers per polymer at 50% quenching as a function of polymer repeat units (PRU) set forth in FIG. 8a.
FIG. 9a is a graphical illustration of polymer repeat units/quencher as a function of polymer molecular weight.
FIG. 9b is a logarithmic graph of the polymer repeat units/quencher as a function of polymer molecular weight set forth in FIG. 9a.
FIG. 10 is an illustration of the fluorescence “turn on” and “turn off” with tethered PTQT′L.
FIG. 11 is an illustration of various molecules used in QTL experiments.
FIG. 12 is a graphical illustration of the absorption spectra of polymer 2 free in solution (solid line) and adsorbed onto clay (dotted line).
FIG. 13 shows a demonstration of a competitive assay with a J-aggregated CDP and a biotin-anthraquinone QTL conjugate.
FIG. 14 is a graphical illustration of the emission spectra of polymer 1 coated onto microspheres: unquenched polymer (solid line), AQS-biotin conjugated quenched polymer 6 (dashed line), and Avidin quench recovered polymer (dot-dashed line).
 The key scientific basis for the polymer-QTL approach is the amplification of quenching of fluorescence that can be obtained with certain charged conjugated polymers and small molecule quenchers. One polymer that has been used is a water soluble polyelectrolyte, 2 methoxy-5-(3-sulfonato-propyloxy)-polyphenylene vinylene (MPS—PPV). Its strong fluorescence can be quenched by the addition of extremely low levels of cationic electron acceptors such as methyl viologen (Mv2+). The fluorescence quenching is measured quantitatively by the Stern-Volmer quenching constant, Ksv (see equation  set forth below). In equation [I], I0 is the fluorescence intensity in the absence of Q and I is the intensity at a quencher concentration, [Q].
 By way of comparison, the quenching constant, Ksv, observed for MV2+ with trans-stilbene, the molecular repeat unit of MPS—PPV, is 15 while that for the polymer MPS—PPV is 1.8×107(see FIG. 1). Chen et al., Proc. Natl. Acad. Sci., 1999:96, 12287-12292. The more than million-fold enhancement of sensitivity to quenching indicates that the complexation of a single quencher molecule to a single site on the polymer chain can quench the fluorescence of the entire polymer chain. In the polymer-QTL approach, the quencher forms a relatively weak complex with the polymer, and the formation of the large and tight complex between the bioagent and the ligand results in a pulling away of the quencher from the polymer and reversal of the fluorescence quenching.
 This concept is illustrated schematically in FIG. 2, using the protein avidin as the receptor. It was determined that the QTL molecule quenches nearly as well as MV2+ and can be used over a wide dynamic range. The QTL molecule shown in FIG. 2 is not removed by other proteins and a quencher that does not contain biotin is not removed by the addition of avidin. The QTL concept is not limited to biotin/avidin combination, it works for other ligand/receptor combinations (e.g., GM1/Choleratoxin, antibody/antigen, and hormone/receptor). Additionally, in the polymer-QTL approach, the identification of the ligand is highly specific to the desired analyte receptor. Thus, the recognition of the analyte receptor can take place at sub-nanomolar levels of the receptor. This specificity of the receptor for the desired analyte results in a highly sensitive mechanism for detecting the desired analyte.
 In the polymer-QTL approach, the sensitivity is defined by three parameters. The first parameter to be determined is the value of Ksv. For systems employing the polymer-QTL approach, Ksv is approximately 107−109 M−1 for a polymer concentration of 10−9 M. The second parameter, the level of minimal detectable variation of I (i.e., ΔI/I) must then be determined. Using modulation of the light sources and lock-in detection, it is reasonable to assume a ΔI/I of an order of 10−3. The third parameter, the number of receptor sites, NR, on the biomolecule of interest can be calculated, since the concentration of quencher removed is given by the equation [Q]=NR[B], where [B] is the concentration of the biomolecule to be detected. For example, for a biotin/avidin system, NR=4. On the other hand, NR is higher for the GM1/Choleratoxin system. Therefore, biomolecules with large numbers of binding sites have additional amplification of sensitivity. Using these simple relations, the trade-off between sensitivity and dynamic range may be estimated as follows.
 First, an expression for the minimum detectable concentration of biomolecule, [ΔB] (=[ΔQ]/NR) can be derived from equation :
[ΔB]=[ΔI/I](1+K sv [Q])/(K sv *N R) 
 Next, the maximum detectable concentration of biomolecule, [B] (i.e., the concentration of B which removes all of the available QTL molecules), is calculated from the equation [B]=[Q]/NR. These expressions are illustrated in FIGS. 3a and 3 b, which show the fluorescence intensity (FIG. 3a) and dynamic range and sensitivity (FIG. 3b) as a function of the QTL molecule. From FIGS. 3a and 3 b, it can be seen that increasing sensitivity is compensated by a decreased dynamic range, and vice versa. However, a compromised value of [Q] can be selected which allows attractive values for both parameters, as illustrated by the arrows in FIG. 3b. In FIG. 3b, [Q] is approximately 10−7 M, the dynamic range is 650, and the sensitivity is 40 pM. By having several solutions with varying concentrations of polymer, sequential detection at a much greater dynamic range and over a range of sensitivities variable from those relevant for detecting bioterrorism agents (less than picomolar concentrations) to those relevant for in vitro and in vivo medical diagnostics (nanomolar to micromolar) is possible.
 In the “biosensor” mode, the polymer-QTL approach functions by having a fluorescent polymer quenched by a specially constructed “quencher-tether-ligand” (QTL) unit as shown in the diagram set forth in FIG. 4. Suitable examples of ligands that can be used in the polymer-QTL approach of the present invention include chemical ligands, hormones, antibodies, antibody fragments, oligonucleotides, antigens, polypeptides, glycolipids, proteins, protein fragments, enzymes, peptide nucleic acids and polysaccharides. Examples of quenchers for use in the QTL molecule include methyl viologen, quinones, metal complexes, fluorescent dyes, and electron accepting, electron donating and energy accepting moieties. The tethering element can be, for example, a single bond, a single divalent atom, a divalent chemical moiety, and a multivalent chemical moiety. However, these examples of the ligands, tethering elements, and quenchers that form the QTL molecule are not to be construed as limiting, as other suitable examples would be easily determined by one of skill in the art.
 The addition of an analyte containing a biological agent specific to the ligand removes the QTL molecule from the fluorescent polymer, which results in a “turning on” of the polymer fluorescence. This technique analyzes the level or presence of the bioagent that is to be detected. Examples of bioagents include proteins, polypeptides, nucleic acids, hormones such as insulin, testosterone, estradiol, drugs such as theophylline, chemical agents such as caffeine, viruses, bacteria such as E. coli, microorganisms such as anthrax, antibodies, antibody fragments, and toxins such as choleratoxin, botulinum, and Shigella.
 Competitive Assay for Polymer-QTL
 For screening small-to-moderate sized molecules that may compete with the natural ligand for a particular bioagent, an attractive alternative is to reverse the process shown in FIG. 4. In this case, the QTL molecule is precomplexed with the bioagent and the polymer fluorescence is initially unquenched as shown in FIG. 5. Addition of a natural or synthetic ligand results in competition for the binding site of the bioagent, release of the QTL molecule, and quenching of the polymer fluorescence.
 In one embodiment, the ligand of the QTL molecule is a molecule that can bind to the estrogen receptor. The usual estrogen receptor ligand, estradiol, does not lend itself easily to forming a QTL molecule since the hydroxyl groups are essential to the binding. This is easily seen in the crystal structure of the estrogen receptor with bound estradiol. However non-natural ligands such as diethylstilbestrol and tamoxifen can readily be tethered to a quencher using reactive sites remote from the hydroxyl groups essential to binding. Thus, for high throughput screening, the QTL:estrogen receptor complex in the presence of the polymer is unquenched. Addition of a ligand that can compete with the QTL molecule releases the QTL molecule and quenches the polymer fluorescence.
 In a preferred embodiment, the QTL molecule contains a xanthine derivative (e.g., caffeine, theophylline) or other agents capable of acting as agonists or antagonists) as the ligand and the complexing agent is one of the adenosine receptors or an antibody to the xanthine. The format for analysis of a xanthine derivative includes a fluorescent polymer in the presence of the QTL:adenosine receptor (or antibody) complex. The polymer fluorescence is unquenched due to the complexing with the QTL molecule. The presence of a potential ligand that can compete for the antibody or adenosine receptor can be detected by the quenching of the polymer fluorescence. The quantitative measurement of fluorescence quenching can also be used to monitor the levels of a specific reagent in samples of variable “ligand” concentration.
 In anther preferred embodiment, the QTL material comprises insulin-like growth factor (IGF1) or a fragment and the complexing agent is an IGF1 antibody, IGF 1 binding protein or IGF1 receptor. This may be used in an assay to monitor levels of growth hormone in a sample.
 In addition, polymer-QTL assays according to the present invention can be used to assay levels of cyclic adenosine monophosphate (cAMP) using a quencher tethered to cAMP and a cAMP antibody as the complexing bioagent. With the QTL:cAMP antibody complex and polymer present, the polymer fluorescence is unquenched. However, quenching occurs when the sample is treated with cAMP. The level of quenching provides a quantitative determination of cAMP.
 Detection of Chemical and Biological Agents using J-Aggregated CDP Polymer-QTL combinations
 The combination of J-aggregate polymer polyelectrolytes and synthetic Quencher-Tether-Ligand (QTL) molecules for fluorescent sensing is a new composition-of-matter for the qualitative and quantitative assay of biological agents.
 Dye polymers having an ionic fluorescent dye chromophore on each repeat unit of a non-conjugated polymer have been previously shown to exhibit strong J-aggregate absorption and fluorescence. (See Roberts et al., U.S. Pat. No. 4,950,587, (1990); Roberts et al., Ceramic Trans. (1991), 19:287; and Place et al., Langmuir (2000) 16:9042.) These polymers can exhibit unusually sharp and intense absorption and fluorescence bands, as shown in FIGS. 6a and 6 b. Jones et al., Langmuir, (2001) 17:2568-2571. Further, their polyelectrolyte properties can render them simultaneously water-soluble plastic materials and substances capable of forming thin films when exposed to appropriate surfaces. (See Place et al., Langmuir (2000) 16:9042; and Place et al., unpublished manuscript).
 In the polymer-QTL approach of present invention, there is an unprecedented high and unique sensitivity of these formally non-conjugated polymers in both solution and various supported formats to luminescence quenching by certain agents capable of accepting energy or electrons from the photoexcited polymer. The polymer luminescence may also be quenched by electron donor molecules. For example, it has been demonstrated that J-aggregate polymers show “superquenching” sensitivity comparable to or greater than that observed for conjugated polyelectrolytes. Further, the photophysical behavior and properties of these polymers offer significant advantages not recognized in previously disclosed systems.
 J-aggregate polymers exhibit readily detectable and characteristic absorption and fluorescence transitions. The narrow and intense fluorescence can easily be detected at polymer concentrations (in repeat units) of 10−9 M. The sensitivity to “superquenching” of these polymers provides a basis for detection of specific chemicals exhibiting quenching properties at extremely low levels (i.e., chemical sensing).
 The narrow absorption and fluorescence bands of these J-aggregated polymers make it possible to follow changes in the luminescence of several different polymers in the same sample (liquid or solid) simultaneously. Since the chromophore does not have to be part of the polymer backbone, it is possible to employ a polymer “scaffold” that possesses independent properties controlling its folding. In one example, poly-1-lysine was used. The protein-mimic “repeat” structure dictates that the polymer will be in one of the common structures observed for folded proteins, for example, an α-helix or a pleated β-sheet. (See Place et al., Langmuir (2000) 16:9042; and Gallot, et al., Liquid Crystals (1997), 23:137). There is preliminary evidence suggesting that the dye-derivatized poly-1-lysine exists preferentially in a β-sheet structure. The control of polymer secondary structure by intramolecular hydrogen bonds renders the polymer much less susceptible to influences from reagents such as ions or macromolecules in the medium, and is therefore potentially useful in a broad range of environments and in the presence of diverse reagents which have been shown to perturb both the structure and luminescent properties of previously disclosed conjugated polyelectrolytes.
 Each polymer molecule constructed from a poly-amino acid contains an additional functionality at each end of the polymer chain. These functionalities may be used to construct more complex “tailored” biosensor molecules or to attach the polymer to a support, ballast, or bead. Thus, these polymers offer possibilities for constructing a variety of “smart” materials or highly tailored molecular systems for advanced sensing concepts.
 Additionally, the construction of a specifically tailored molecule that combines a quencher moiety (Q) with a specific biological ligand or recognition molecule (L) which is linked by a tether (T) (i.e., a QTL molecule) can afford the ability to use these polymers as a platform for the detection of a broad range of biological molecules.
 As for previously disclosed fluorescent polyelectrolytes, the QTL molecule having an opposite overall charge to the polyelectrolyte binds weakly and nonspecifically to the polymer by a combination of coulombic and hydrophobic interactions. Quenching at the level of close to one molecule of quencher per polymer chain has been observed. The L portion of the QTL molecule is designed to recognize and bind strongly and specifically to a biological molecule (e.g., protein, nucleic acid, virus, or cell) such that addition of the bioagent to a quenched polymer-QTL results in the removal of the QTL molecule from the polymer and the release of polymer fluorescence. Depending on the nature of the quencher, the bioagent-QTL complex may be non-luminescent or it may emit light at the characteristic luminescence of Q.
 One specific J-aggregate polymer used in experimentation by the present inventors has a cationic cyanine dye on each repeat unit and thus is a polycation. (See FIG. 6a). A specific advantage of this polymer is that it is not subject to quenching by inorganic cations. The very short excited state lifetime of J-aggregated cyanines (less than 50 ps) also limits the possibility that the excited dye aggregate can be quenched by dynamic interactions with potential quenchers not associating with the polymer in the ground state. This polymer has been prepared in a variety of molecular weights ranging from monomer to small oligomer to polymers having a number of polymer repeat units (PRU) ranging from 6-904. In water and water-dimethylsulfoxide, the polymer exists predominantly as a J-aggregate when the number of PRUs exceeds 110. However, the fluorescence emission of the polymer arises from a J-aggregate for polymers having 33 PRUs or higher. Quenching of this series of polymers by the anionic electron acceptor, anthraquinone disulfonate in water and water-dimethylsulfoxide (50:50 volume:volume), shows that the extent of “superquenching” increases with molecular weight and the extent of J-aggregation (see Tables 1, 2 and FIG. 7). The values obtained for very dilute solutions of the polymers with 263, 401 and 904 PRUs for Ksv are 5×108−1.2×109 M−1 and are the highest known Stern-Volmer quenching constants. Although the smallest oligomer (5-6 PRU's) exhibits “superquenching”, the extent of quenching can be enhanced by 2-3 orders of magnitude by increasing the number of PRU's and the extent of aggregation. Plots of quenchers per polymer and effective number of repeat units per quencher at 50% quenching indicate that the ideal size for use of the polymer in solution saturates at about 250 PRU (see FIGS. 8a, 8 b and FIGS. 9a, 9 b).
TABLE 1 Fluorescence Quantum Yields for Cyanine Dye Polymers at 22° C. MW of starting DMSO/H2O polylysine PRU (50%) H2O Lifetime X2 189,000 904 2.6% 0.86% 9 ps (95.0%), 1.23 57 ps (4.4%) 84,000 401 2.5% 0.70% 50,000 263 2.0% 1.0% 9 ps (91.3%), 1.37 57 ps (8%) 23,000 110 2.6% 0.76% 13,200 63 2.0% 1.4% 6,900 33 1.2% 1.3% 500-2,000 5˜6 2.7% 2.1% 60 ps (51.6%), 1.37 255 ps (34.2%), 849 ps (13.5%) monomer 1 1.7% 0.3%a 152 ps (85.7%), 0.92 652 ps (14.3%)
TABLE 2 Fluorescence Quenching of Cyanine Dye Polymers by Anthraquinone Sulfonate at 22° C. MW of starting KSV (M−1) in KSV (M−1) KSV (M−1) in polylysine PRU DMSO/H2O (50%) in H2O CH2Cl2 189,000 904 5.2 × 108 4.6 × 108 1.5 × 107 84,000 401 4.8 × 108 50,000 263 4.6 × 108 4.8 × 108 23,000 110 1.6 × 108 13,200 63 7.5 × 107 5.5 × 107 6,900 33 3.4 × 107 4.3 × 107 2.7 × 107 500-2,000 5˜6 1.0 × 106 monomer 1 630a
 Extensive studies of the quenching and unquenching of a J-aggregate polymer with 263 PRU's have been carried out both in solution and with the polymer adsorbed onto supports. In solution, this polymer is quenched by very small amounts of anionic electron or energy acceptors. The corresponding QTL conjugates with biotin and xanthines as the ligands show similar high quenching sensitivities of the polymer. The QTL conjugates quench the fluorescence of the polymer but relatively little unquenching is observed when the protein avidin is added to solutions quenched by the biotin QTL's. The failure to observe significant unquenching is attributed to the tendency of the 263 PRU cyanine polymer to associate strongly with neutral or charged biomacromolecules such as proteins and nucleic acids in aqueous solution.
 J-aggregate polymers (which include but are not limited to CDP) offer the following significant and distinct advantages over conjugated polymers previously examined:
 1. A J-aggregate polycation polymer should not be quenched or modified by inorganic cations (such as copper) at physiological concentrations. On the other hand, inorganic cations quench anionic conjugated polymers. Inorganic anions may bind to the J-aggregate polymer, but they should not affect fluorescence in most cases.
 2. J-aggregate polymer structure is controlled and likely predictable based on the polypeptide backbone and is likely to be in an α-helix or β-sheet arrangement that should persist in a variety of media. The polymer structure for previously disclosed conjugated polymers varies widely in different media.
 3. The J-aggregate polymer exhibits extremely sharp and intense absorption and fluorescence such that it can be used (and its fluorescence detected) at concentrations as low as 10−9 M in solution and even lower in other formats. The fluorescence line width is over 10 times narrower than that for previously disclosed conjugated polymers.
 4. J-aggregate polymers should retain sharp and narrow absorption and fluorescence band properties in a variety of media and complex fluids. The absorption and fluorescence of conjugated polymers varies widely in different media.
 5. J-aggregate polymer and polymer-QTL formats may be coated onto anionic surfaces without losing their J-aggregate absorption or fluorescence properties. The absorption and fluorescence of conjugated polyelectrolytes is drastically altered upon film formation.
 6. Several different “color” J-aggregate polymers may be obtained by synthetic manipulation of the cyanine dye portion of the polymer repeat unit without changing the inherent structure of the polymer (i.e., it is controlled by the peptide backbone). In the visible spectrum, this will allow 10-15 distinct color bands in a single sample. Previously disclosed conjugated polymers only allow 2-3 distinct color bands in the visible spectrum.
 7. The peptide-based polymers contain additional (terminal) functional groups that can be used to append the polymer to a ballast, support, or to a QTL unit. These functional groups are absent in previously disclosed conjugated polymers.
 8. J-aggregate polymers can be readily synthesized in a variety of molecular weights varying the size and sensitivity of the polymer to quenching by various agents.
 Supported Polymer-QTL Platforms for Bioagent Detection
 1. Tethered Polymer-OTL (P—T—O—T'—L) as custom agent detectors
 The fluorescent polymer-QTL approach to bioagent detection can be significantly improved by directly linking the polymer by a covalent tether to the QTL unit. In this way, a specific fluorescent polymer-QTL combination can be used at near single-molecule levels to detect a specific bioagent. The “molecular sensor”—P—T—Q—T'—L is constructed such that in the absence of the bioagent to be sensed, the fluorescence of the polymer (P) is quenched. Since electron transfer quenching is only effective through space over very short distances, the removal of the quencher away from the fluorescent polymer by only a few angstroms can result in an “unquenching” of the polymer fluorescence. In the absence of a receptor available for complexing with the ligand, the polymer will have the tethered quencher in close proximity and its fluorescence will be quenched. This concept is diagramed schematically below in Table 3.
TABLE 3 Absence of bioagent (B): Addition of B results in polymer fluorescence association between quenched due to ground state L and B and pulls Q away from P, association of P and Q. turning on the polymer fluorescence.
 In aqueous or mixed aqueous-organic solvent environments, hydrophobic and coulombic (i.e., the quencher has opposite charge to the polymer) effects favor a “folded” configuration. As can be seen in FIG. 10, the addition of a receptor results in a “pulling away” of the quencher-ligand and “turns on” the polymer fluorescence. As discussed above, if the QTL molecule is precomplexed with a bioagent, addition of a natural or synthetic ligand can release the PTQT′L from the bioagent. Thus, the tethered format also provides a platform in which the polymer-QTL functions as a “turn-off” fluorescence assay, as shown in FIG. 10. The tether (T) linking the polymer (P) to the quencher (Q) is sufficiently flexible such that close approach of P and Q within the distance required for resonant energy transfer or electron transfer is possible. Examples of suitable tethers (T) include, without limitation, polyethylene, polyethylene oxides, polyamides, non-polymeric organic structures of at least about 7-20 carbon atoms, and related materials. The second tether (T′) linking Q and the bioagent ligand (L) must be sufficiently short such that binding of bioagent (B) to the quenched polymer results in pulling the quencher away from the polymer and “turning on” the polymer fluorescence. The complex P—T—Q—T′—L:B is thus a fluorescent “tagged” bioagent and can be tracked and isolated by virtue of its fluorescence.
 By developing a suite of P—T—Q—T′—L molecules where P and L are varied, it is possible to have polymers which fluoresce with different “colors” in response to the presence of specific agents. This provides a convenient means for analyzing for several agents in the same sample. The quencher to be used in this format will most preferably be a species that quenches in a non-radiative fashion and that exhibits a sharp fall-off of quenching efficiency with quencher-polymer separation. The most appropriate quenchers are those that quench the polymer fluorescence by electron transfer and that form weak ground state charge-transfer complexes. Examples of the polymer include, but are not limited to, fluorescent polymers (including conjugated polymers), conjugated polyelectrolytes and J-aggregating dye polymers (including polyelectrolytes). The J-aggregating dye polyelectrolytes presently offer the best possibilities for synthesis of a suite of molecules for multiplexing due to the narrow spectral band of emission in these polymers.
 PTQT′L can be used to assay several different ligand-receptor combinations including, but not limited to, hormone-protein (and other small molecule-receptor combinations), protein-protein, polypeptide-protein, and glycolipid-protein.
 It should be noted that for all of the above-described applications, the fluorescent polymer may be most conveniently employed when it is anchored either covalently or by ionic adsorption onto a support such as a bead or plate and used in either a static or flow-through mode.
 2. Anchored Polymer-tethered OTL systems for bioagent detection
 A second variation of the tethered polymer platform involves the use of a totally anchored polymer: QTL unit on a surface, probe, or bead. This format is especially convenient for both detection and isolation of a bioagent. In this format, a unit much like the P—T—Q—T′—L is itself anchored either covalently or non-covalently on a surface, bead, or other support by covalent or non-covalent linkages. Addition of a bioagent (B) that binds with L increases the separation between P and Q and reverses the quenching that is observed in the absence of B. In this format, the binding of the bioagent both anchors it to the surface where the polymer-quencher-ligand species is isolated and turns on the fluorescence of the polymer.
 The same restrictions on the quenching nature of Q discussed above with respect to a tethered polymer-QTL (P—T—Q—T′—L) system also apply to anchored polymer-tethered QTL systems. The advantage is the simultaneous detection and immobilization of the bioagent on the surface containing the polymer-quencher-ligand reagent. This format can be used for both liquid samples and aerosols and may be used for continuous monitoring of streams of liquids or vapor. The addition or flowing of a stream of bioagent “recognizing” the specific QTL molecule results in the removal of the bioagent from the stream and the “turning on” of the polymer fluorescence. This concept is diagramed in Table 4.
TABLE 4 Absence of bioagent (B): Capture of B results in polymer fluorescence association between quenched due to ground state L and B and separation of Q and P, association of P and Q, turning on fluorescence from the An acrosol or liquid containing polymer immobilization of B. B flows over the surface contain- ing the polymer-quencher-ligand.
 When combined with anchored polymer+QTL formats, a very powerful way of simultaneously detecting several bioagents and reducing the chances of “false positives” is provided. By placing the various tethered polymer-QTL's in different wells or on photodiodes in a multi-well plate or photodiode array, a large number of compounds or samples may be assayed at one time. This is a useful application in the high-throughput screening of drugs and in clinical medical diagnostics.
 Many of the same phenomena observed in solution can also occur in interfacial and supported formats. Additionally, the use of supported or combined formats allows a remarkable tuning, and in some cases, enhancement of superquenching that offers powerful advantages for biosensing applications. In many instances, coating the fluorescent polyelectrolyte onto a surface of a bead or particle is effectively irreversible such that the material is not removed, even on repeated washings.
 It was recently reported that CDP polymer 2, shown in FIG. 11, can be adsorbed onto glass slides coated with Laponite clay. (See Place et al., Langmuir (2000) 16:9042). In this format, the polymer exhibits J-aggregation similar to that observed for the polymer in solution. It has now been determined that polymer 2 can be transferred to laponite clay suspensions in solution. In this case, although the polymer exhibited an absorption spectrum that is somewhat blue-shifted as compared to the J-aggregate in solution (see FIG. 12), it still exhibited chromophore aggregation characterized by a red-shift from the monomer spectrum. In the supported format, the quenching charge reversal may be tuned by adjusting the level of coverage of the polymers on the clay particles. Although from size and charge considerations it is expected that the clay would take up several molecules (perhaps as many as 20) of polymer 2 per particle, careful titration of the dye with clay indicated that the number of polymer molecules adsorbed per particle may be much lower (see Jones et al. Langmuir (2001) 17:2568-2571). Titration of the dye with Laponite suspensions until no additional uptake of polymer occurred resulted in very small changes in light scattering from dissolved polymer 2 to Laponite-supported polymer 2, suggesting that each clay particle bears at most a small number of polymer molecules or an average of about one polymer molecule per clay particle. Under these conditions, the supported polymer 2 exhibited moderately enhanced superquenching by the anionic anthraquinone 5 (Ksv=1.1×108 M−1) as compared to aqueous solutions of the same substrate and quencher (Ksv=7×107M−1).
 In addition, it was recently reported that polymer 2 in solution could be quenched by the anthraquinone-biotin conjugate 6, illustrated in FIG. 11, but was not “unquenched” upon the addition of avidin, presumably due to the strong association of avidin and polymer 2. (See Jones et al., Supra). Remarkably, it has been discovered that the use of polymer 2 in the clay supported format described above allows both enhanced superquenching by anthraquinone-biotin conjugate 6, as well as quantitative “unquenching” upon the addition of avidin. Therefore, the use of supported formats permits a reduction of the sensitivity of the polymers to nonspecific interactions with proteins and at the same time allows polymer-quencher interactions to be tuned. In this way, the anionic bioconjugate 6 can be used to demonstrate the quench-unquench biosensing by specific binding and removal of the bioconjugate by its receptor.
 When polymers 1 and 2 are mixed together in dilute aqueous solution there is clear evidence of energy transfer from the higher energy excited states of polymer 1 to the lower energy emitting J-aggregate state of polymer 2. This interpolymer energy transfer can be observed at very low concentrations and can be reasonably assigned to association between the two polymers. Although the predominant fluorescence of an ensemble formed from an equimolar (in repeat units) mixture of the two polymers is from the J-aggregate band of polymer 2, the addition of cationic viologen 3 illustrated in FIG. 11 results in a quenching of the fluorescence. The fluorescence of the ensemble is also quenched by the addition of anionic anthraquinone 5. Thus, the fluorescence of the ensemble can be quenched by both cationic and anionic electron acceptors and the photophysical properties of the individual polymers are strongly coupled. The quenching by both cations and anions suggests that while the ensemble is overall near neutral, individual regions of each polymer possess sufficient residual charge to strongly bind small counterions and permit superquenching by both cationic and anionic quenchers.
 While the use of mixtures may provide a means for gaining enhanced quenching, it is also desirable to be able to use mixtures of fluorescent polymers in applications where their individual behavior is retained. This has been accomplished by using a format where one of the two polymers is supported and the other remains in solution. In particular, it was discovered that coating of polymer 2 onto Laponite clay followed by the addition of polymer 1 in an aqueous solution lead to a mixture that demonstrated independent behavior of the two polymers both with respect to their fluorescence and to fluorescence quenching. The fluorescence of this mixture with no quenchers added was the simple sum of the fluorescence of each polymer individually, i.e., no energy transfer or fluorescence quenching is observed. The addition of viologen 3 to this mixture only quenched the fluorescence of polymer 1, while addition of an anion, i.e., anionic anthraquinone 5, to the mixture resulted in the selective quenching of the fluorescence of polymer 2. This indicates that the use of a supported format may allow the simultaneous sensing of different antigens by several different polymers in the same suspension.
 By layering fluorescent polyelectrolytes onto oppositely-charged surfaces, superquenching effects may be tuned, nonspecific interactions may be eliminated, and the use of fluorescent polyectrolytes in quantitative bio assays may be optimized. Also, mixtures of oppositely-charged polyelectrolytes offer a means of both charge-tuning and enhanced light harvesting by energy transfer.
 Detection of Chemical and Biological Agents Using Electrophoretic Dye Polymer-QTL Combinations
 1. Electronhoretic fluorescent polymer OTL combinations for bioagent detection
 The fluorescent polymer-QTL approach to bioagent detection can be greatly expanded in terms of scope of detection by using an electric field-assisted separation of the QTL-bioagent complex from the fluorescent polymer. A variety of polymers and QTL reagents have been developed such that in the absence of an agent and an electric field, the fluorescence of the polymer is quenched by the formation of a complex between the polymer and the QTL.
TABLE 5 Conventional QTL: Absence of Bioagent: Addition of Bioagent: Polymer fluorescence is The strong association quenched by complex formation, between L and B results in a new with QTL. No fluorescence is complex that is too large to permit detected or the fluorescence of the Polymer-QTL association Q or a Polymer-QTL complex and the QTL is pulled away from may be detected the polymer resulting in a “turn on” of the polymer fluorescence.
 In the QTL-based biosensors discussed above, the complex between the polymer and the QTL molecule is broken by the formation of a complex between the ligand L and the bioagent, B. (See Table 5). This scheme works well for bioagent-ligand combinations where the ligand is much smaller than the bioagent-ligand complex. However, often times, the ligand and bioagent will be of comparable size such that the resulting steric effect on binding of the ligand to the bioagent is not sufficient enough to result in the breaking of the polymer-QTL association. In these cases, an electric field may be used to dissociate the polymer from the bioagent-QTL complex. The electric field effect takes advantage of the fact that the fluorescent polymer to be used is a polyelectrolyte (either polycation or polyanion) and the bioagent to be detected (e.g., protein, nucleic acid, or larger complex biomolecule) will in general also have a large positive or negative charge.
 In contrast, the QTL molecule used in electrophoretic detection will usually be a simple mono or divalent cation or anion. For this simplest electric field-assisted QTL detection, it is necessary to select a polymer of opposite net charge from the bioagent to be detected. By studying the electric field effect on solutions, bilayers, or gels containing the polymer-QTL complex, it can be determined how strong a field must be applied to promote the separation of the polymer-QTL complex. This field will generally be much stronger then that necessary to separate the polymer or bioagent. Thus, in the absence of an applied electric field, the addition of the bioagent will result in complex formation between the polymer-QTL and the bioagent (i.e., polymer-QTL:B). However, upon application of an electric field, the polymer and the bioagent-QTL will separate and the fluorescence of the polymer will be regenerated as the quencher is removed. If the quencher portion of the QTL is fluorescent, its fluorescence may also be detected at an independent wavelength when the electric field is applied. The effect of the electric field is shown below schematically in Table 6.
TABLE 6 Electric Field Assisted QTL: No Applied Field Absence of Bioagent: Addition of Bioagent: Polymer fluorescence is The strong association quenched by complex formation between L and B results in a with QTL. No fluorescence is new complex that consists of detected or the fluorescence of oppositely charged polymer and Q or a Polymer-QTL complex bioagent components. In the may be detected absence of an electric field the fluorescence of the polymer remains quenched. Electric Field Applied:
 The electric field applied may be either AC (alternating current) or DC (static). In the former, the fluorescence generated by transient cleavage of the polymer-QTL:B complex may be observed as a modulation of the fluorescence signal corresponding to the frequency of the AC. If the applied field is DC, macroscopic separation of the complex may be achieved by conventional electrophoretic techniques. The combination of electrophoresis employing a modulating field with fluorescence detection offers the advantage of sensitive detection with the ability to distinguish between specific and non-specific binding events.
 2. Electrophoretic fluorescent polymer-tethered OTL combinations for bioagent detection
 Tethered polymer-QTL formats (P—T—Q—T′—L) may also be used in an electrophoretic format with similar advantages to those discussed above for the “simple” polymer-QTL approach to biosensing. In this case, the tethered polymer-QTL complex will be quenched in the “resting mode” (i.e., no bioagent and no applied electric field) provided that the tether is sufficiently “flexible” to permit the folding of the quencher to a configuration permitting near or close contact with the polymer. Application of an applied AC or DC field may result in transient or permanent separation, respectively, of the polymer and tethered QTL provided that the polymer and QTL components have a substantially different net charge. As shown in Table 7, fluorescence is absent in the absence of an AC or DC field and “turned on” by the application of a sufficiently strong AC or DC field to pull the QTL and polymer apart.
TABLE 7 No Electric Field: Fluorescence Electric Field Applied: Fluorescence Quenched Observed
 Addition of the bioagent will result in complex formation but will not necessarily result in sufficient separation of the QTL:B complex from the polymer to “unquench” the polymer fluorescence. However, application of an applied AC or DC field will result in transient or permanent separation and the AC or DC field necessary to affect the separation will generally be much different (usually smaller) than that required to separate the polymer and QTL in the absence of B. (See Table 8). Thus, the electrophoretic effect can be used reversibly to sense specific bioagents.
TABLE 8 No Electric Field: Fluorescence Electric Field Applied: Fluorescence Quenched Observed Presence of Bioagent: Fluorescence Quenched in absence of field, unquenched when field is applied but the field response (either AC or DC) will be much different in presence and absence of B.
 3. Electrophoretic anchored polymer-QTL combinations
 The electrophoretic mode of bioagent detection may be used effectively in gels, bilayers, or solutions in formats where the fluorescent polyelectrolyte is tethered to a support in contact with the medium. In one embodiment, the polymer is tethered to the support and the QTL unit associates with the polymer through non-covalent interactions to quench the polymer in the absence of an applied electric field and bioagent. Applying the field in sufficient strength will cause the charged QTL component to migrate with a consequent “unquenching” of the polymer fluorescence. Addition of the bioagent to be detected in the absence of an electric field may or may not cause “unquenching” of the polymer fluorescence, depending on the size and steric effect resulting from bioagent-ligand complexation. However, even if there is no “unquenching” of the polymer fluorescence in the absence of an electric field, application of an electric field will result in the migration of the bioagent-QTL complex, a reversal of the fluorescence quenching and detection of the fluorescence from Q in the case where Q is itself fluorescent.
 In general, the charge on the bioagent is different and much larger than the charge of the QTL molecule, and migration of QTL:B in the electric field is very different from that of a QTL molecule alone and is very easy to detect by fluorescence or calorimetric assay. As set forth above, the detection of specific, known bioagents will be easy and reliable due to the ability to predict the migration pattern at specific field strengths. The ability to tether the polymer to the surface should enhance the ability to separate the polymer and “tagged” bioagent and to use “flow formats” and the polymer reversibly.
 4. Electrophoretic anchored polymer-tethered QTL combination
 As described above, formats using a polymer tethered to a QTL molecule and a polymer tethered to a support offer advantages for specific detection/isolation applications and for reversible operation of the biosensor. Electrophoretic/fluorescence sensing using a format with the tethered polymer-QTL itself tethered to a support in a bilayer, gel, or solution offer some additional advantages. In the absence of an electric field and bioagent, the tethered polymer-QTL quenches the polymer fluorescence. The addition of the bioagent to form a QTL:B complex may or may not result in the “unquenching” of the polymer fluorescence. In cases where no “unquenching” occurs, application of an electric field (i.e., AC or DC) can result in unquenching either in the presence or absence of bioagent. However, field strengths will be very different for the two cases. Furthermore, at some limiting electric field strength, it should be possible to remove the bioagent thus rendering the tethered polymer-QTL reusable.
 Having generally described this invention, a further understanding can be obtained by reference to certain specific examples which are provided herein for purposes of illustration only and are not intended to be limiting unless otherwise specified.
 A preferred embodiment for using a cyanine polymer/QTL approach consists of a competitive assay based on selective quenching of a cyanine polymer solution. For example, a 263 polymer repeat unit (PRU) cyanine polymer can be conveniently used in a fluorescence quench competitive bioassay. A competitive assay involving the avidin-biotin receptor-ligand system was conducted as follows: 500 μl of 0.1 μM of this polymer was added to the filtrate (lower) chamber of each of 3 separate Microcon YM-30 centrifugal filter vials. In each of these devices the filtrate chamber is separated from the retentate (upper) chamber by a 30 kilodalton (KD) nominal molecular weight cutoff (NMWCO) cellulose membrane. This membrane is impermeable to the 66 KD protein avidin but allows the biotin-anthraquinone conjugate to pass. A competitive assay was demonstrated by first complexing the anthraquinone-biotin QTL with avidin in a molar ratio 0.8:1 (QTL conjugate:avidin). Since each avidin has four biotin binding sites, this sub-stoichiometric ratio ensures full binding of all QTL conjugate to avidin. The three retentate chambers were charged with a.) 0.5 μM D-Biotin, b. and c.) 0.8 μM AQS-biotin conjugate complexed with 1.0 μM avidin. The 3 tubes were then each sealed and incubated for 10 minutes, after which time 0.5 μM D-Biotin was added to vial c. All three vials were then centrifuged for 1 minute at 12,000 g to allow permeable species in the retentates to mix with the filtrate containing the cyanine polymer. The fluorescence emission of all three filtrates was then measured at 20.0° C.+/−0.1° C. on a SPEX FluoroMax-3. Upon centrifugation, the biotin-avidin complex did not pass through the membrane, and no quenching was observed when only the avidin-QTL conjugate sample (vial b) was centrifuged. Also, no quenching was observed if only biotin (vial a) is present. As shown in FIG. 13, upon adding biotin to the QTL-avidin solution in a 4:1 ratio (biotin:avidin), competition of biotin with the biotin-anthraquinone QTL conjugate for the avidin binding sites resulted in release of the QTL, and subsequent to passage of QTL through the membrane quenching occurred.
 In an aqueous solution, anionic polymer 1 illustrated in FIG. 11 is strongly quenched by cationic electron acceptors such as methyl viologen (Formula 3 illustrated in FIG. 11) or the viologen-biotin conjugate, Formula 4, shown in FIG. 11. (Chen, L.; McBranch. D. W.; Wang. H.-L.; Helgeson. R.; Wudl. F.; Whitten, D. G. Proc. Natl. Acad. Sci. 1999, 96, 12287-12292: Whitten. D.; Chen. L.; Jones. R.; Bergstedt, T.; Heeger. P.; and McBranch. D. in “Sensors and Optical Switches”, Molecular and Supramolecular Photochemistry Vol. 7, Eds. K. S. Schanze and V. Ramamurthy, Marcel Dekker, Inc. Pub. In press).
 As shown previously, the “unquenching” observed when the protein avidin is added to quenched solutions of polymer 1 complexed with QTL 4 provides a quantitative assay for the sensitive detection of a protein. Similarly, the cationic cyanine polymer 2 exhibits superquenching with the anionic anthraquinone disulfonate 5 and the corresponding conjugate 6, chemical structures are depicted in FIG. 11. (Jones et al., Supra). (Jones. R. M.; Bergstedt, T. S.; Buscher, C. T.; McBranch, D.; and Whitten. D. Langmuir, in press.) The inventors have examined quenching with this series of polymers and quenchers when the polymers are adsorbed onto oppositely charged supports. In particular, polymers 1 and 2 were coated from aqueous solution onto commercial (Pharmacia) cationic (Source 30 Q-average size, 30 microns) and anionic (Source 30 S) polystyrene beads, respectively. The coating of the beads with the polymers proceeded as follows: Beads were loaded into a 0.45 μm ultrafiltration tube and washed 3 times with water under gentle centrifuigal force (100 g) to remove preservative. The beads were then resuspended in a polymer solution of known volume and concentration and then incubated for 1 hour at room temperature. Separation of free unadsorbed polymer from polymer-coated beads was effected by centrifugation for 3 minutes at 100 g. The coated beads were then washed 3 times with water to remove passively adsorbed polymer before they were stored as an aqueous suspension at 4° C. In each case, a “charge reversal” for the quenching of the supported polymers was observed. Thus, polystyrene-supported polymer 2 was quenched by viologen 3, but not by the anthraquinone sulfonate 5 and polystyrene-supported polymer 1 was quenched by anthraquinone sulfonate 5 but not by viologen 3.
 The effect of the charge reversal on the quenching of the supported polymers extends to quenching-unquenching applications. Polystyrene-supported polymer 1 was quenched by the anionic anthraquinone-biotin conjugate 6 and addition of avidin resulted in a regeneration of the polymer fluorescence (see FIG. 14). Addition of avidin to unquenched polystyrene-supported polymer 1 resulted in no detectable change in the polymer emission and there was no fluorescence recovery when avidin was added to suspensions of polystyrene-supported polymer 1 that have been quenched by anthraquinone sulfonate 5. The fluorescence of polystyrene-supported polymer 1 was also quenched by the anionic dye-biotin conjugate 7, illustrated in FIG. 11. In this case, the quenching of the polymer fluorescence occurs via energy transfer and accompanying the quenching is a sensitization of the fluorescence of the dye-biotin conjugate 7. A quantitative “unquenching” of the polymer fluorescence can be obtained by adding an avidin solution to a suspension of the quenched polymer, this indicating removal of the conjugate from the supported polymer.
 The invention of this application is described above both generically, and with regard to specific embodiments. A wide variety of alternatives known to those of ordinary skill in the art can be selected within the generic disclosure, and example are not be interpreted as limiting, unless specially so indicated. The invention is not otherwise limited, except for the recitation of the claims set forth below. All references cited herein are incorporated in their entirety.
|Cited Patent||Filing date||Publication date||Applicant||Title|
|US1899781 *||Apr 27, 1932||Feb 28, 1933||Twiss John Russell||Stomach tube or the like|
|US2464933 *||Sep 28, 1946||Mar 22, 1949||Kaslow Arthur L||Gastrointestinal tube|
|US4133315 *||Dec 27, 1976||Jan 9, 1979||Berman Edward J||Method and apparatus for reducing obesity|
|US4134405 *||Jan 10, 1977||Jan 16, 1979||Smit Julie A||Catheter and intestine tube and method of using the same|
|US4270542 *||Oct 2, 1979||Jun 2, 1981||Plumley Peter F||Gastro-intestinal tubes|
|US4279251 *||Jun 5, 1979||Jul 21, 1981||Willy Rusch Gmbh & Co. Kg||Tube for enteral treatment|
|US4315509 *||Oct 16, 1978||Feb 16, 1982||Smit Julie A||Insertion and removal catheters and intestinal tubes for restricting absorption|
|US4403604 *||May 13, 1982||Sep 13, 1983||Wilkinson Lawrence H||Gastric pouch|
|US4501264 *||Dec 16, 1980||Feb 26, 1985||Rockey Arthur G||Medical sleeve|
|US4580568 *||Oct 1, 1984||Apr 8, 1986||Cook, Incorporated||Percutaneous endovascular stent and method for insertion thereof|
|US4607618 *||Jan 11, 1985||Aug 26, 1986||Angelchik Jean P||Method for treatment of morbid obesity|
|US4641653 *||Feb 19, 1985||Feb 10, 1987||Rockey Arthur G||Medical sleeve|
|US4648383 *||Jul 22, 1985||Mar 10, 1987||Angelchik Jean P||Peroral apparatus for morbid obesity treatment|
|US4763653 *||Feb 5, 1987||Aug 16, 1988||Rockey Arthur G||Medical sleeve|
|US4823808 *||Jul 6, 1987||Apr 25, 1989||Clegg Charles T||Method for control of obesity, overweight and eating disorders|
|US4948843 *||May 30, 1989||Aug 14, 1990||Eastman Kodak Company||Dye polymer/sol-gel composites|
|US4950587 *||Sep 2, 1988||Aug 21, 1990||Eastman Kodak Company||J-aggregating dye polymers as spectral sensitizers for silver halide photographic compositions|
|US5035706 *||Oct 17, 1989||Jul 30, 1991||Cook Incorporated||Percutaneous stent and method for retrieval thereof|
|US5037387 *||Jan 24, 1990||Aug 6, 1991||Corpak, Inc.||Method of positioning an enteral feeding tube within a patient's body|
|US5041126 *||Sep 14, 1988||Aug 20, 1991||Cook Incorporated||Endovascular stent and delivery system|
|US5236423 *||Jun 5, 1992||Aug 17, 1993||Endomed Corporation||Facilitating endoscopy|
|US5246456 *||Jun 8, 1992||Sep 21, 1993||Wilkinson Lawrence H||Fenestrated gastric pouch|
|US5279953 *||Jun 24, 1992||Jan 18, 1994||Esca Genetics Corporation||In vivo production of taxanes|
|US5282824 *||Jun 15, 1992||Feb 1, 1994||Cook, Incorporated||Percutaneous stent assembly|
|US5306300 *||Sep 22, 1992||Apr 26, 1994||Berry H Lee||Tubular digestive screen|
|US5314444 *||Apr 2, 1993||May 24, 1994||Cook Incorporated||Endovascular stent and delivery system|
|US5314472 *||Oct 1, 1991||May 24, 1994||Cook Incorporated||Vascular stent|
|US5314473 *||Jan 5, 1993||May 24, 1994||Godin Norman J||Prosthesis for preventing gastric reflux into the esophagus|
|US5318530 *||Dec 6, 1991||Jun 7, 1994||Bissel Medical Products, Inc.||Gastrointestinal tube with inflatable bolus|
|US5387235 *||Oct 21, 1992||Feb 7, 1995||Cook Incorporated||Expandable transluminal graft prosthesis for repair of aneurysm|
|US5401241 *||May 7, 1992||Mar 28, 1995||Inamed Development Co.||Duodenal intubation catheter|
|US5420016 *||Feb 18, 1994||May 30, 1995||Serim Research Corporation||Test device and kit for detecting helicobacter pylori|
|US5443498 *||Dec 6, 1993||Aug 22, 1995||Cook Incorporated||Vascular stent and method of making and implanting a vacsular stent|
|US5507767 *||Jan 15, 1992||Apr 16, 1996||Cook Incorporated||Spiral stent|
|US5507771 *||Apr 24, 1995||Apr 16, 1996||Cook Incorporated||Stent assembly|
|US5611787 *||Oct 13, 1994||Mar 18, 1997||Methodist Hospital Of Indiana, Inc.||Method and device for gastric line insertion|
|US5612221 *||May 30, 1995||Mar 18, 1997||Dade Chemistry Systems Inc.||Avidin-binding fluorescing and quenching reagent for use in homogeneous assays|
|US5624430 *||Nov 28, 1994||Apr 29, 1997||Eton; Darwin||Magnetic device to assist transcorporeal guidewire placement|
|US5630797 *||Jan 17, 1995||May 20, 1997||Imagyn Medical, Inc.||Everting catheter system and method of utilizing the same|
|US5662713 *||Sep 14, 1995||Sep 2, 1997||Boston Scientific Corporation||Medical stents for body lumens exhibiting peristaltic motion|
|US5665064 *||May 12, 1995||Sep 9, 1997||Sherwood Medical Company||Gastroenteric feeding tube for endoscopic placement and method of use|
|US5713832 *||Apr 23, 1996||Feb 3, 1998||Product Development Consulting Inc.||Massaging furniture with electric vibration device and eccentric rotor|
|US5720776 *||Jun 7, 1995||Feb 24, 1998||Cook Incorporated||Barb and expandable transluminal graft prosthesis for repair of aneurysm|
|US5755777 *||Oct 8, 1996||May 26, 1998||Cook Incorporated||Expandable transluminal graft prosthesis for repair of aneurysm|
|US5800456 *||Jun 13, 1997||Sep 1, 1998||Cook Incorporated||Spiral stent|
|US5800526 *||Jul 24, 1997||Sep 1, 1998||Endotex Interventional Systems, Inc.||Multi-anchor stent|
|US5876445 *||Nov 26, 1996||Mar 2, 1999||Boston Scientific Corporation||Medical stents for body lumens exhibiting peristaltic motion|
|US6027508 *||Oct 3, 1996||Feb 22, 2000||Scimed Life Systems, Inc.||Stent retrieval device|
|US6099552 *||Nov 12, 1997||Aug 8, 2000||Boston Scientific Corporation||Gastrointestinal copression clips|
|US6200336 *||Jun 2, 1999||Mar 13, 2001||Cook Incorporated||Multiple-sided intraluminal medical device|
|US6251132 *||Oct 20, 1998||Jun 26, 2001||Boston Scientific Corporation||Prosthesis delivery|
|US6355421 *||Oct 27, 1998||Mar 12, 2002||Boston Probes, Inc.||Methods, kits and compositions pertaining to PNA molecular beacons|
|US6387114 *||Mar 27, 2001||May 14, 2002||Scimed Life Systems, Inc.||Gastrointestinal compression clips|
|US6508833 *||Mar 12, 2001||Jan 21, 2003||Cook Incorporated||Multiple-sided intraluminal medical device|
|US6524335 *||Dec 9, 1998||Feb 25, 2003||William A. Cook Australia Pty. Ltd.||Endoluminal aortic stents|
|US6524336 *||Apr 6, 1999||Feb 25, 2003||Cook Incorporated||Endovascular graft|
|US6530951 *||Oct 23, 1997||Mar 11, 2003||Cook Incorporated||Silver implantable medical device|
|US6537247 *||Jun 4, 2001||Mar 25, 2003||Donald T. Shannon||Shrouded strain relief medical balloon device and method of use|
|US6540789 *||Nov 10, 2000||Apr 1, 2003||Scimed Life Systems, Inc.||Method for treating morbid obesity|
|US6558400 *||May 30, 2001||May 6, 2003||Satiety, Inc.||Obesity treatment tools and methods|
|US6565597 *||Jul 17, 2000||May 20, 2003||Med Institute, Inc.||Stent adapted for tangle-free deployment|
|US6589213 *||Nov 2, 1998||Jul 8, 2003||Wilson-Cook Medical Incorporated||Body canal intrusion instrumentation having bi-directional coefficient of surface friction with body tissue|
|US6589275 *||Feb 24, 1999||Jul 8, 2003||William Cook Eurpoe Aps||Stent device|
|US6589731 *||May 4, 2000||Jul 8, 2003||The Regents Of The University Of California||Method for detecting biological agents|
|US6675809 *||Aug 27, 2001||Jan 13, 2004||Richard S. Stack||Satiation devices and methods|
|US6676692 *||Apr 27, 2001||Jan 13, 2004||Intek Technology L.L.C.||Apparatus for delivering, repositioning and/or retrieving self-expanding stents|
|US6695875 *||Mar 14, 2001||Feb 24, 2004||Cook Incorporated||Endovascular stent graft|
|US6699263 *||Apr 5, 2002||Mar 2, 2004||Cook Incorporated||Sliding suture anchor|
|US6743640 *||May 8, 2001||Jun 1, 2004||Qtl Biosystems Llc||Fluorescent polymer-QTL approach to biosensing|
|US6755869 *||Jan 25, 2002||Jun 29, 2004||Boston Scientific Corporation||Intragastric prosthesis for the treatment of morbid obesity|
|US6773440 *||Jul 2, 2002||Aug 10, 2004||Satiety, Inc.||Method and device for use in tissue approximation and fixation|
|US20010020190 *||Mar 26, 2001||Sep 6, 2001||Taylor Thomas V.||Perorally insertable gastroesophageal anti-reflux valve prosthesis and tool for implantation thereof|
|US20020040804 *||Dec 11, 2001||Apr 11, 2002||Vanhoutte Eddy W.||Electrically conductive wire|
|US20020091439 *||Jan 30, 2002||Jul 11, 2002||Baker Steve G.||Graft assembly having support structure|
|US20030040808 *||Apr 8, 2002||Feb 27, 2003||Stack Richard S.||Satiation devices and methods|
|US20030050684 *||Sep 10, 2001||Mar 13, 2003||Abrams Robert M.||Internal restraint for delivery of self-expanding stents|
|US20030109892 *||Jan 14, 2003||Jun 12, 2003||Deem Mark E.||Obesity treatment tools and methods|
|US20030109931 *||Jan 25, 2002||Jun 12, 2003||Boston Scientific Corporation||Intragastric stent for duodenum bypass|
|US20030109935 *||Jan 25, 2002||Jun 12, 2003||Boston Scientific Corporation||Intragastric prosthesis for the treatment of morbid obesity|
|US20030120265 *||Dec 5, 2002||Jun 26, 2003||Deem Mark E.||Obesity treatment tools and methods|
|US20030149467 *||Nov 7, 2002||Aug 7, 2003||Linder Richard J.||Methods, systems and devices for delivering stents|
|US20040024386 *||Mar 27, 2003||Feb 5, 2004||Deem Mark E.||Obesity treatment tools and methods|
|US20040044357 *||Aug 30, 2002||Mar 4, 2004||James Gannoe||Stented anchoring of gastric space-occupying devices|
|US20040092892 *||Oct 31, 2003||May 13, 2004||Jonathan Kagan||Apparatus and methods for treatment of morbid obesity|
|US20040098079 *||Jun 30, 2003||May 20, 2004||Cook Incorporated||Thoracic aortic stent graft deployment device|
|US20040107004 *||Jan 9, 2003||Jun 3, 2004||Seedling Enterprises, Llc||Bariatric sleeve|
|US20040117031 *||Jan 16, 2003||Jun 17, 2004||Stack Richard S.||Satiation devices and methods|
|US20040122452 *||Dec 5, 2003||Jun 24, 2004||Satiety, Inc.||Obesity treatment tools and methods|
|US20040122453 *||Dec 5, 2003||Jun 24, 2004||Satiety, Inc.||Obesity treatment tools and methods|
|US20040133147 *||Oct 27, 2003||Jul 8, 2004||Woo Sang Hoon||Intestinal bypass device to treat obesity|
|US20040136971 *||Oct 14, 2003||Jul 15, 2004||David Scharp||Implantation of encapsulated biological materials for treating diseases|
|US20040138525 *||Jan 15, 2003||Jul 15, 2004||Usgi Medical Corp.||Endoluminal tool deployment system|
|US20040138529 *||Jun 9, 2003||Jul 15, 2004||Usgi Medical Corp.||Endoluminal tool deployment system|
|US20040138760 *||Nov 25, 2003||Jul 15, 2004||Schurr Marc O||Medical implant|
|US20040138761 *||Jan 5, 2004||Jul 15, 2004||Stack Richard S.||Satiation devices and methods|
|US20040143342 *||Jan 16, 2003||Jul 22, 2004||Stack Richard S.||Satiation pouches and methods of use|
|US20040148034 *||Oct 31, 2003||Jul 29, 2004||Jonathan Kagan||Apparatus and methods for treatment of morbid obesity|
|US20040153167 *||Jan 16, 2003||Aug 5, 2004||Stack Richard S.||Positioning tools and methods for implanting medical devices|
|US20040158331 *||Mar 12, 2003||Aug 12, 2004||Stack Richard S.||Method and apparatus for modifying the exit orifice of a satiation pouch|
|Citing Patent||Filing date||Publication date||Applicant||Title|
|US7144950||Sep 17, 2003||Dec 5, 2006||The Regents Of The University Of California||Conformationally flexible cationic conjugated polymers|
|US7208122||Dec 18, 2002||Apr 24, 2007||Massachusetts Institute Of Technology||Emissive polymers and devices incorporating these polymers|
|US7214489||Jun 20, 2003||May 8, 2007||The Regents Of The University Of California||Methods and compositions for detection and analysis of polynucleotides using light harvesting multichromophores|
|US7270956||Aug 26, 2003||Sep 18, 2007||The Regents Of The University Of California||Methods and compositions for detection and analysis of polynucleotides using light harvesting multichromophores|
|US7393503||Oct 17, 2005||Jul 1, 2008||Massachusetts Institute Of Technology||Emissive polymers and devices incorporating these polymers|
|US7462325||Nov 30, 2001||Dec 9, 2008||Nomadics, Inc.||Luminescent polymer particles|
|US7662309||Oct 17, 2005||Feb 16, 2010||Massachusetts Institute Of Technology||Emissive polymers and devices incorporating these polymers|
|US7666594||Jan 31, 2006||Feb 23, 2010||The Regents Of The University Of California||Methods for assaying a sample for an aggregant|
|US7811755||Jan 10, 2006||Oct 12, 2010||The Regents Of The University Of California||Methods and articles for strand-specific polynucleotide detection with cationic multichromophores|
|US7897684||Jan 10, 2006||Mar 1, 2011||The Regents Of The University Of California||Conjugated polymers suitable for strand-specific polynucleotide detection in homogeneous and solid state assays|
|US7914984||Nov 21, 2006||Mar 29, 2011||The Regents Of The University Of California||Conformationally flexible cationic conjugated polymers|
|US7943062||Jan 26, 2010||May 17, 2011||Massachusetts Institute Of Technology||Emissive polymers and devices incorporating these polymers|
|US8076842||Mar 1, 2006||Dec 13, 2011||The Regents Of The University Of California||Multilayer polymer light-emitting diodes for solid state lighting applications|
|US8158437||Aug 2, 2007||Apr 17, 2012||Massachusetts Institute Of Technology||Luminescent detection of hydrazine and hydrazine derivatives|
|US8198096||Sep 29, 2006||Jun 12, 2012||Massachusetts Institute Of Technology||Emissive polymers and devices incorporating these polymers|
|US8309672||Sep 6, 2005||Nov 13, 2012||The Regents Of The University Of California||Soluble conjugated polymers|
|US8455265||Feb 29, 2008||Jun 4, 2013||Stc.Unm||Surface grafted conjugated polymers|
|US8669055||Oct 12, 2010||Mar 11, 2014||The Regents Of The University Of California||Methods and articles for strand-specific polynucleotide detection with conjugated polymers|
|US8759444||Dec 24, 2012||Jun 24, 2014||The Regents Of The University Of California||Conjugated polymers for use in homogeneous and solid state assays|
|US8795781||Sep 6, 2005||Aug 5, 2014||The Regents Of The University Of California||Methods and devices utilizing soluble conjugated polymers|
|US8835113||Sep 3, 2013||Sep 16, 2014||The Regents Of The University Of California||Methods and compositions for assaying a sample for an aggregant|
|US8841072||Nov 21, 2013||Sep 23, 2014||The Regents Of The University Of California||Methods and compositions for detection and analysis of polynucleotides using light harvesting multichromophores|
|US8857279||Mar 3, 2008||Oct 14, 2014||William P. Hanson||Analyte screening and detection systems and methods|
|US8993335||Feb 13, 2004||Mar 31, 2015||The Regents Of The University Of California||Methods for detection and analysis of polynucleotide-binding protein interactions|
|US9017766||Sep 17, 2004||Apr 28, 2015||The Regents Of The University Of California||Methods and devices comprising soluble conjugated polymers|
|US9085799||Aug 14, 2014||Jul 21, 2015||The Regents Of The University Of California|
|US20040142344 *||Aug 26, 2003||Jul 22, 2004||The Regents Of The University Of California|
|US20050059168 *||Sep 17, 2003||Mar 17, 2005||The Regents Of The University Of California||Conformationally flexible cationic conjugated polymers|
|US20050147534 *||Apr 12, 2004||Jul 7, 2005||Massachusetts Institute Of Technology||Emissive sensors and devices incorporating these sensors|
|WO2009111389A1 *||Mar 2, 2009||Sep 11, 2009||Hanson Technologies, Inc.||Analyte screening and detection systems and methods|
|U.S. Classification||435/7.9, 435/6.19|
|International Classification||C12Q1/68, G01N33/483, G01N21/78, G01N21/77, G01N21/64, G01N33/542, G01N33/58|
|Cooperative Classification||Y10S436/808, G01N2021/6439, G01N33/582, G01N21/6428, G01N2021/6432, G01N33/542|
|European Classification||G01N33/58D, G01N21/64H, G01N33/542|